Contrasting Envoy Medical (COCH) & Its Rivals

Envoy Medical (NASDAQ:COCH) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it contrast to its peers? We will compare Envoy Medical to related companies based on the strength of its institutional ownership, analyst recommendations, earnings, dividends, profitability, risk and valuation.

Risk & Volatility

Envoy Medical has a beta of 2.35, suggesting that its share price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s peers have a beta of 1.28, suggesting that their average share price is 28% more volatile than the S&P 500.

Valuation and Earnings

This table compares Envoy Medical and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.89
Envoy Medical Competitors	$1.41 billion	$234.66 million	14.66

Envoy Medical’s peers have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Envoy Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Insider & Institutional Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings for Envoy Medical and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	400	1402	2527	116	2.53

Envoy Medical currently has a consensus target price of $9.00, suggesting a potential upside of 614.29%. As a group, “Surgical appliances & supplies” companies have a potential upside of 37.15%. Given Envoy Medical’s stronger consensus rating and higher possible upside, research analysts plainly believe Envoy Medical is more favorable than its peers.

Summary

Envoy Medical peers beat Envoy Medical on 7 of the 13 factors compared.

Envoy Medical Company Profile

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.